Medical News

RSS

KINAXO, AstraZeneca enter oncology research collaboration

KINAXO Biotechnologies GmbH announced today that it has entered into a collaboration with AstraZeneca. Under the terms of the agreement, KINAXO will apply its technology platform to support one of AstraZeneca's oncology programs. KINAXO will employ high-end mass spectrometry-based technologies to quantitatively analyze posttranslational protein modifications on a proteome-wide scale.

5 Jan 2011

20% of patients who received implantable cardioverter-defibrillators did not meet guidelines for receipt of ICD

A study that included more than 100,000 patients who received implantable cardioverter-defibrillators (ICDs) found that about 20 percent did not meet evidence-based guidelines for receipt of an ICD, and that these patients had a significantly higher risk of in-hospital death than individuals who met criteria for receiving an ICD, according to a study in the January 5 issue of JAMA.

5 Jan 2011

EUSA receives FDA Priority Review status for ERWINAZE BLA

EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, today announced that its Biologics License Application for ERWINAZE(R) has been accepted for filing and awarded Priority Review status by the U.S. Food and Drug Administration.

5 Jan 2011

Administration of therapeutic hypothermia for TBI should depend on clinical condition of individual patients

Lowering the body temperature of patients soon after they have suffered a severe brain injury may reduce neurologic complications and improve outcomes. The safety of therapeutic hypothermia for traumatic brain injury (TBI) has been demonstrated in national studies. According to a Roundtable Discussion of renowned experts in the field, when and how it is administered should depend on the clinical condition of individual patients.

5 Jan 2011

Star Scientific plans to submit new, moist-snuff product for FDA evaluation

Star Scientific Inc.'s plan to submit a new, moist-snuff product for evaluation by the Food and Drug Administration as a "modified risk" tobacco product shows the vital importance of the new law giving the FDA the authority to regulate tobacco products and any health claims used to market them.

5 Jan 2011

OrbusNeich expands patent protection for Genous endothelial progenitor cell capture technology

OrbusNeich today announced that the United States Patent and Trademark Office (USPTO) has granted an additional patent expanding protection of the company's Genous endothelial progenitor cell (EPC) capture technology.

5 Jan 2011

SIVAC initiative helps establish Mongolian National Immunization Technical Advisory Group

The inaugural meeting of the Mongolian National Immunization Technical Advisory Group (NITAG) was held at the Ministry of Health in Ulaanbaatar on December 6, 2010.

5 Jan 2011

New Wisconsin Governor backs legal challenge

Taking the position that the law is unconstitutional, the state's new republican governor gave the attorney general permission to proceed with legal action.

5 Jan 2011

arGEN-X's alliance with Lilly highlights potential of SIMPLE Antibody platform

arGEN-X BV, a biopharmaceutical company focused on the discovery and development of human antibodies using its proprietary SIMPLE Antibody platform, today announced it has entered into an alliance with Eli Lilly and Company ("Lilly") to discover and develop novel therapeutic antibody products against targets submitted by Lilly.

5 Jan 2011

Unique vaccine produces long-lasting anti-cocaine immunity in mice

Researchers from The Scripps Research Institute, Weill Cornell Medical College, and Cornell University have produced a long-lasting anti-cocaine immunity in mice by giving them a unique vaccine that combines bits of the common cold virus with a particle that mimics cocaine.

5 Jan 2011

Alkeus and Columbia University enter license agreement for potential therapies for dry-AMD, Stargardt disease

Alkeus Pharmaceuticals and Columbia University announced today that they have entered into a license agreement for a set of potential therapies for the treatment of dry age-related macular degeneration (dry-AMD), Stargardt disease, and other degenerative diseases of the eye. Left untreated, these conditions often lead to impaired vision and even blindness.

5 Jan 2011

Celgene announces regulatory submissions for blood cancer therapies REVLIMID and ISTODAX

Celgene International Sàrl announced regulatory submissions for its blood cancer therapies REVLIMID (lenalidomide) and ISTODAX (romidepsin).

5 Jan 2011

GLUMETZA tablets are now available to wholesalers and physicians

Santarus, and Depomed, today announced that supply of GLUMETZA® 500 mg to wholesalers and retailers has resumed. GLUMETZA is a once-daily, extended release formulation of metformin and is approved for use in adults with type 2 diabetes mellitus.

5 Jan 2011

DMC announces contracts over $60M after sealing partnership with Vanguard Health Systems

Detroit Medical Center (DMC) officials today made good on their promise to get right to work on hospital construction projects, announcing contracts totaling over $60 million just four days after DMC's landmark partnership with Vanguard Health Systems was sealed.

5 Jan 2011

Men are more willing to receive HPV vaccine, trend may help reduce cancer deaths

Men are more willing to receive human papillomavirus vaccine when they learn the vaccine can prevent cancer, according to a recent University of North Carolina at Chapel Hill study.

5 Jan 2011

Betulin in birch bark appears to provide metabolic benefits

An ingredient found in abundance in birch bark appears to have an array of metabolic benefits, according to new studies in animals that are reported in the January issue of Cell Metabolism, a Cell Press publication.

5 Jan 2011

Canadian Cancer Society launches sixth annual Driven to Quit Challenge

Results of an Angus Reid Public Opinion survey conducted in December show that 20 per cent of Ontario adults are current tobacco users, including cigarettes, cigars and chew tobacco, and that half of them have tried unsuccessfully to quit in the past.

5 Jan 2011

Study identifies sailing injuries

Just as the site for the 2013 America's Cup has been announced, a study from Rhode Island Hospital highlights that the sport isn't always smooth sailing. The study was published recently in the journal Wilderness and Environmental Medicine.

5 Jan 2011

ReproCELL to enter collaborative iPS cell-derived hepatocytes R&D agreement with NIBIO

ReproCELL, Inc. (CEO: Chikafumi Yokoyama PhD) announces today that the company will enter a collaborative R&D agreement with the National Institute of Biomedical Innovation (NIBIO; Director General: Koichi Yamanishi; Osaka, Japan), which could offer new hepatocyte derived from human iPS (induced pluripotent stem) cells used for an effective in-vitro drug screening for hepatic toxicity and liver metabolism.

5 Jan 2011

HMS receives contracts to perform dependent eligibility audit services

HMS, a wholly owned subsidiary of HMS Holdings Corp., today announced that it had been awarded contracts by both the Iowa Department of Administrative Services and the Maine State Employee Health Commission to perform dependent eligibility audit services for their State Employee Health Benefit Plans.

5 Jan 2011

Medical News

KINAXO, AstraZeneca enter oncology research collaboration

20% of patients who received implantable cardioverter-defibrillators did not meet guidelines for receipt of ICD

EUSA receives FDA Priority Review status for ERWINAZE BLA

Administration of therapeutic hypothermia for TBI should depend on clinical condition of individual patients

Star Scientific plans to submit new, moist-snuff product for FDA evaluation

OrbusNeich expands patent protection for Genous endothelial progenitor cell capture technology

SIVAC initiative helps establish Mongolian National Immunization Technical Advisory Group

New Wisconsin Governor backs legal challenge

arGEN-X's alliance with Lilly highlights potential of SIMPLE Antibody platform

Unique vaccine produces long-lasting anti-cocaine immunity in mice

Alkeus and Columbia University enter license agreement for potential therapies for dry-AMD, Stargardt disease

Celgene announces regulatory submissions for blood cancer therapies REVLIMID and ISTODAX

GLUMETZA tablets are now available to wholesalers and physicians

DMC announces contracts over $60M after sealing partnership with Vanguard Health Systems

Men are more willing to receive HPV vaccine, trend may help reduce cancer deaths

Betulin in birch bark appears to provide metabolic benefits

Canadian Cancer Society launches sixth annual Driven to Quit Challenge

Study identifies sailing injuries

ReproCELL to enter collaborative iPS cell-derived hepatocytes R&D agreement with NIBIO

HMS receives contracts to perform dependent eligibility audit services

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News